Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.080
-0.040 (-1.89%)
At close: Jun 27, 2025, 4:00 PM
2.060
-0.020 (-0.96%)
After-hours: Jun 27, 2025, 7:55 PM EDT
Aytu BioPharma Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for Aytu BioPharma.
Price Target: $0.00 (0.00%)
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for Aytu BioPharma.
Recommendation Trends
| Rating | Mar '23 | Apr '23 | May '23 | Jun '23 | Jul '23 | Aug '23 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Initiates $5 | Strong Buy | Initiates | $5 | +140.38% | Aug 9, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +861.54% | May 31, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $220 → $120 | Strong Buy | Maintains | $220 → $120 | +5,669.23% | Jul 21, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $220 → $100 | Buy | Maintains | $220 → $100 | +4,707.69% | May 17, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $480 → $220 | Strong Buy | Maintains | $480 → $220 | +10,476.92% | Apr 28, 2022 |
Financial Forecast
Revenue This Year
72.27M
from 81.00M
Decreased by -10.78%
Revenue Next Year
78.55M
from 72.27M
Increased by 8.68%
EPS This Year
0.73
from -2.86
EPS Next Year
1.39
from 0.73
Increased by 88.89%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 74.4M | 80.9M | 103.9M | |||
| Avg | 72.3M | 78.5M | 101.0M | |||
| Low | 69.4M | 75.5M | 97.0M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -8.2% | 11.9% | 32.3% | |||
| Avg | -10.8% | 8.7% | 28.5% | |||
| Low | -14.3% | 4.4% | 23.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.76 | 1.43 | 1.46 |
| Avg | 0.73 | 1.39 | 1.42 |
| Low | 0.71 | 1.33 | 1.36 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 94.4% | 5.2% |
| Avg | - | 88.9% | 2.2% |
| Low | - | 81.5% | -1.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.